natgillin/translations-raw huggingface dataset:
Where proposed label claims include requirements for use of the preparation with other specified plant protection products or adjuvants as a tank mix, the mixture must achieve the desired effect and comply with the principles referred to in points 2.1.1 to 2.1.4.
Kadar se na predlagani oznaki zahteva uporaba pripravka z drugimi fitofarmacevtskimi sredstvi ali dodatki v mešanici v tanku škropilnice, mora mešanica doseči želeni učinek in biti v skladu z načeli iz točk 2.1.1 do 2.1.4.
Where proposed label claims include recommendations for use of the preparation with specified plant protection products or adjuvants as a tank mix, Member States shall not accept the recommendations unless they are justified.
Kadar se na predlagani oznaki priporoča uporaba pripravka z določenimi fitofarmacevtskimi sredstvi ali dodatki v mešanici v tanku škropilnice, države članice sprejmejo priporočila le, če so upravičena.
There must be no relevant phytotoxic effects on treated plants or plant products except where the proposed label indicates appropriate limitations of use.
Fitofarmacevtsko sredstvo na tretirane rastline ali rastlinske proizvode ne sme učinkovati fitotoksično, razen kadar so na predlagani oznaki navedene ustrezne omejitve uporabe.
There must be no reduction of yield at harvest due to phytotoxic effects below that which could be obtained without the use of the plant protection product, unless this reduction is compensated for by other advantages such as an enhancement of the quality of the treated plants or plant products.
Pridelek ob spravilu zaradi fitotoksičnih učinkov pripravka ne sme biti manjši od pridelka, doseženega brez uporabe fitofarmacevtskega sredstva, razen kadar se izgube nadomestijo z drugimi prednostmi uporabe, npr. z izboljšanjem kakovosti tretiranih rastlin ali rastlinskih proizvodov.
There must be no unacceptable adverse effects on the quality of treated plants or plant products, except in the case of adverse effects on processing where proposed label claims specify that the preparation must not be applied to crops to be used for processing purposes.
Fitofarmacevtsko sredstvo ne sme imeti nesprejemljivih škodljivih učinkov na kakovost tretiranih rastlin ali rastlinskih proizvodov, razen pri škodljivih učinkih na predelavo, kadar je na predlagani oznaki izrecno navedeno, da se pripravek ne sme uporabljati na kulturah, namenjenih za nadaljnjo predelavo.
There must be no unacceptable adverse effects on treated plants or plant products used for propagation or reproduction, such as effects on viability, germination, sprouting, rooting and establishment, except where proposed label claims specify that the preparation should not be applied to plants or plant products to be used for propagation or reproduction.
Fitofarmacevtsko sredstvo ne sme imeti nesprejemljivih škodljivih učinkov na tretirane rastline ali rastlinske proizvode, namenjene za razmnoževanje ali vegetativno razmnoževanje, kot so vpliv na življenjsko moč, kaljivost, odganjanje, ukoreninjenje in začetek rasti, razen kadar je na predlagani oznaki izrecno navedeno, da se pripravek ne sme uporabljati na rastlinah ali rastlinskih proizvodih, namenjenih za razmnoževanje ali vegetativno razmnoževanje.
There must be no unacceptable impact on succeeding crops, except where proposed label claims specify that particular crops, which would be affected, must not be grown following the treated crop.
Fitofarmacevtsko sredstvo ne sme imeti nesprejemljivih učinkov na naslednje kulture, razen kadar je na predlagani oznaki izrecno navedeno, da se posamezne kulture, ki bi bile prizadete, ne smejo gojiti za tretiranimi kulturami.
There must be no unacceptable impact on adjacent crops, except where proposed label claims specify that the preparation should not be applied when particular sensitive adjacent crops are present.
Fitofarmacevtsko sredstvo ne sme imeti nesprejemljivih učinkov na sosednje kulture, razen kadar je na predlagani oznaki izrecno navedeno, da se pripravek ne sme uporabljati v bližini občutljivih sosednjih kultur.
Where proposed label claims include requirements for use of the preparation with other plant protection products or adjuvants, as a tank mix, the mixture must comply with the principles referred to in points 2.2.1 to 2.2.6.
Kadar se na predlagani oznaki zahteva uporaba pripravka z drugimi fitofarmacevtskimi sredstvi ali dodatki v mešanici v tanku škropilnice, mora biti mešanica v skladu z načeli iz točk 2.2.1 do 2.2.6.
The proposed instructions for cleaning the application equipment must be both practical and effective so that they can be applied with ease so as to ensure the removal of residual traces of the plant protection product which could subsequently cause damage.
Predlagana navodila za čiščenje opreme za nanašanje morajo biti praktična in učinkovita, njihova uporaba pa preprosta, tako da se zagotovi odstranitev sledi ostankov fitofarmacevtskega sredstva, ki bi lahko povzročili škodo.
An authorisation for a plant protection product intended to eliminate vertebrates shall be granted only when:
Registracija fitofarmacevtskega sredstva, namenjenega za zatiranje vretenčarjev, se odobri samo, če:
death is synchronous with the extinction of consciousness, or
smrt nastopi sočasno z izgubo zavesti, ali
death occurs immediately, or
smrt nastopi v trenutku, ali
vital functions are reduced gradually without signs of obvious suffering.
življenjske funkcije postopno pojemajo brez očitnih znakov trpljenja.
For repellent products, the intended effect shall be obtained without unnecessary suffering and pain for the target animals.
Odvračala morajo delovati tako, da predvideni učinek dosežejo brez povzročanja nepotrebnega trpljenja in bolečin ciljnim živalim.
No authorisation shall be granted if the extent of operator exposure in handling and using the plant protection product under the proposed conditions of use, including dose and application method, exceeds the AOEL.
Registracija se ne odobri, če obseg izpostavljenosti izvajalca tretiranja pri ravnanju s fitofarmacevtskim sredstvom med uporabo pri predlaganih pogojih, vključno z odmerkom in načinom nanašanja, presega sprejemljivo raven izpostavljenosti izvajalca tretiranja.
Moreover, the conditions of the authorisation shall be in compliance with the limit value established for the active substance and/or toxicologically relevant compound(s) of the product in accordance with Council Directive 98/24/EC [6] and in accordance with Directive 2004/37/EC of the European Parliament and of the Council [7].2.4.1.2. Where the proposed conditions of use require use of items of protective clothing and equipment, no authorisation shall be granted unless those items are effective and in accordance with the relevant EU provisions and are readily obtainable by the user and unless it is feasible to use them under the circumstances of use of the plant protection product, taking into account climatic conditions in particular.
Poleg tega so pogoji za registracijo v skladu z mejnimi vrednostmi za aktivne snovi in/ali toksikološko relevantne spojine proizvoda v skladu z Direktivo Sveta 98/24/ES [6] in Direktivo 2004/37/ES [7] Evropskega parlamenta in Sveta.2.4.1.2 Kadar se pri predlaganih pogojih uporabe zahteva uporaba zaščitne obleke in opreme, se registracija ne odobri, če oprema ni učinkovita in v skladu z ustreznimi določbami EU ter uporabniku dostopna in enostavna za uporabo v predvidenih okoliščinah uporabe fitofarmacevtskega sredstva, še zlasti ob upoštevanju podnebnih razmer.
Plant protection products which because of particular properties or if mishandled or misused could lead to a high degree of risk must be subject to particular restrictions such as restrictions on the size of packaging, formulation type, distribution, use or manner of use.
Fitofarmacevtska sredstva, ki zaradi posebnih lastnosti ali ob napačnem ravnanju ali napačni uporabi lahko povzročijo veliko tveganje, je treba omejiti, npr. z omejitvami glede velikosti embalaže, vrste formulacije, distribucije, uporabe ali načina uporabe.
Moreover, those plant protection products may not be authorised for use by non-professional users which are classified as:
Poleg tega se navedena fitofarmacevtska sredstva lahko registrirajo samo za profesionalno uporabo, ki je opredeljena kot:
acute toxicity category 1 and 2 for any route of uptake, provided the ATE (acute toxicity estimate) of the product does not exceed 25 mg/kg bw for the oral route of uptake or 0,25 mg/l/4h for the inhalation of dust, mist or fume;
akutna toksičnost kategorije 1 in 2 za kateri koli način vnosa, če ocena akutne toksičnosti sredstva ne presega 25 mg/kg telesne teže za oralni vnos ali 0,25 mg/l/4h za vnos z vdihavanjem prahu, meglice ali plina;
STOT (single exposure), category 1 (oral), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 25 mg/kg bw;
STOT (enkratna izpostavljenost), kategorija 1 (oralni vnos), če njihova razvrstitev temelji na prisotnosti razvrščenih snovi, ki kažejo znatne neletalne toksične učinke pri priporočenih vrednostih pod 25 mg/kg telesne teže;
STOT (single exposure), category 1 (dermal), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 50 mg/kg bw;
STOT (enkratna izpostavljenost), kategorija 1 (dermalni vnos), če njihova razvrstitev temelji na prisotnosti razvrščenih snovi, ki kažejo znatne neletalne toksične učinke pri priporočenih vrednostih pod 50 mg/kg telesne teže;
STOT (single exposure), category 1 (inhalation of gas/vapour), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 0,5 mg/l/4h;
STOT (enkratna izpostavljenost), kategorija 1 (vnos z vdihavanjem plina/pare), če njihova razvrstitev temelji na prisotnosti razvrščenih snovi, ki kažejo znatne neletalne toksične učinke pri priporočenih vrednostih pod 0,5 mg/l/4h;
STOT (single exposure), category 1 (inhalation of dust/mist/fume), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 0,25 mg/l/4h.
STOT (enkratna izpostavljenost), kategorija 1 (vnos z vdihavanjem prahu/meglice/dima), če njihova razvrstitev temelji na prisotnosti razvrščenih snovi, ki kažejo znatne neletalne toksične učinke pri priporočenih vrednostih pod 0,25 mg/l/4h.
Waiting and re-entry safety periods or other precautions must be such that the exposure of bystanders or workers exposed after the application of the plant protection product does not exceed the AOEL levels established for the active substance or toxicologically relevant compound(s) in the plant protection product nor any limit values established for those compounds in accordance with the EU provisions referred to in point 2.4.1.1.
Varnostne karence in karence za ponovni dostop ali drugi varnostni ukrepi morajo zagotavljati, da izpostavljenost drugih navzočih oseb ali delavcev po nanašanju fitofarmacevtskega sredstva ne presega vrednosti sprejemljive ravni izpostavljenosti izvajalca tretiranja, določenih za aktivno snov ali toksikološke relevantne spojine fitofarmacevtskega sredstva, niti drugih mejnih vrednosti, določenih za navedene spojine v skladu z določbami EU iz točke 2.4.1.1.
Waiting and re-entry safety periods or other precautions must be established in such a way that no adverse impact on animals occurs.
Varnostne karence in karence za ponovni dostop ali drugi varnostni ukrepi je treba določiti tako, da fitofarmacevtsko sredstvo ne povzroča škodljivih učinkov na živali.
Waiting and re-entry periods or other precautions to ensure that the AOEL levels and limit values are respected must be realistic; if necessary special precautionary measures must be prescribed.
Varnostne karence in karence za ponovni dostop ali drugi varnostni ukrepi, ki zagotavljajo upoštevanje ustreznih vrednosti sprejemljive ravni izpostavljenosti izvajalca tretiranja in mejnih vrednosti, morajo biti realistični; če je potrebno, se morajo določiti posebni previdnostni ukrepi.
Authorisations must ensure that residues occurring reflect the minimum quantities of the plant protection product necessary to achieve adequate control corresponding to good agricultural practice, applied in such a manner (including pre-harvest intervals or withholding periods or storage periods) that the residues at harvest, slaughter or after storage, as appropriate, are reduced to a minimum.
Registracije morajo zagotoviti, da so ostanki fitofarmacevtskih sredstev, ki odražajo najmanjši odmerek sredstev, potreben za ustrezno varstvo rastlin v skladu z dobro kmetijsko prakso (vključno s karencami pred žetvijo, obdobji prepovedi uporabe ali časi skladiščenja) ob spravilu, zakolu rejnih živali ali po skladiščenju, čim manjši.
Where the new circumstances under which the plant protection product is to be used do not correspond to those under which a MRL (maximum residue limit) was established previously, Member States shall not grant an authorisation for the plant protection product unless the applicant can provide evidence that its recommended use shall not exceed the MRL established under Regulation (EC) No 396/2005 of the European Parliament and of the Council [8].2.4.2.3. Where a MRL exists Member States shall not grant an authorisation for the plant protection product unless the applicant can provide evidence that its recommended use shall not exceed that MRL, or unless a new MRL has been established under Regulation (EC) No 396/2005.
Kadar nove okoliščine predvidene uporabe fitofarmacevtskega sredstva ne ustrezajo okoliščinam, za katere je bila predhodno določena mejna vrednost ostanka, države članice ne odobrijo registracije fitofarmacevtskega sredstva, razen če lahko vlagatelj dokaže, da s priporočeno uporabo fitofarmacevtskega sredstva ne bo presežena mejna vrednost ostanka iz Uredbe (ES) št. 396/2005 Evropskega parlamenta in Sveta [8].2.4.2.3 Kadar je določena mejna vrednost ostanka, države članice ne odobrijo registracije fitofarmacevtskega sredstva, razen če lahko vlagatelj dokaže, da s priporočeno uporabo fitofarmacevtskega sredstva ne bo presežena navedena mejna vrednost ostanka, ali če je bila v skladu z Uredbo (ES) št. 396/2005 določena nova mejna vrednost ostanka.
In the cases referred to in points 2.4.2.2, each application for an authorisation must be accompanied by a risk assessment taking into account worst-case potential exposure of consumers in the Member State concerned on the basis of good agricultural practice.
V primerih iz točke 2.4.2.2 se mora vsaki vlogi za registracijo priložiti ocena tveganja, ki na podlagi dobre kmetijske prakse upošteva največjo možno izpostavljenost potrošnikov v zadevni državi članici.
Taking into account all registered uses, the proposed use shall not be authorised if the best possible estimate of dietary exposure exceeds the ADI.
Ob upoštevanju vseh registriranih načinov uporabe se predlagana uporaba ne odobri, če najboljša možna ocena izpostavljenosti s prehrano presega sprejemljivi dnevni vnos.
Where the nature of residues is affected during processing, a separate risk assessment may need to be carried out under the conditions provided for in point 2.4.2.4.
Kadar postopki predelave vplivajo na naravo ostankov fitofarmacevtskih sredstev, je morda treba izdelati ločeno oceno možnega tveganja pod pogoji iz točke 2.4.2.4.
Where the treated plants or plant products are intended to be fed to animals, residues occurring shall not have an adverse effect on animal health.
Kadar so tretirane rastline ali rastlinski proizvodi namenjeni za krmo, ostanki fitofarmacevtskih sredstev ne smejo negativno učinkovati na zdravje živali.
No authorisation shall be granted if the active substance and, where they are of significance from the toxicological, ecotoxicological or environmental point of view, metabolites and breakdown or reaction products, after use of the plant protection product under the proposed conditions of use:
Registracija se ne odobri, če aktivna snov in metaboliti, reakcijski ali razgradni produkti, kadar so toksikološko, ekotoksikološko ali okoljsko pomembni, po uporabi fitofarmacevtskega sredstva pri predlaganih pogojih uporabe:
during tests in the field, persist in soil for more than 1 year (i.e. DT90 > 1 year and DT50 > 3 months), or
pri testih na prostem ostanejo v tleh več kot eno leto (tj. DT90 > 1 leto in DT50 > 3 mesece) ali
during laboratory tests, form non-extractable residues in amounts exceeding 70 % of the initial dose after 100 days with a mineralisation rate of less than 5 % in 100 days,
pri laboratorijskih testih tvorijo neekstraktibilne ostanke, ki po 100 dneh količinsko presegajo 70 % začetnega odmerka pri stopnji mineralizacije manjši od 5 % v 100 dneh,
unless it is scientifically demonstrated that under field conditions there is no accumulation in soil at such levels that unacceptable residues in succeeding crops occur and/or that unacceptable phytotoxic effects on succeeding crops occur and/or that there is an unacceptable impact on the environment, in accordance with the relevant requirements provided for in points 2.5.1.2, 2.5.1.3, 2.5.1.4 and 2.5.2.
razen če se znanstveno dokaže, da v terenskih razmerah ni akumulacije v tleh v takih količinah, ki bi povzročile prisotnost nesprejemljivih ostankov v naslednjih kulturah in/ali nesprejemljive fitotoksične učinke na naslednje kulture in/ali nesprejemljivi vpliv na okolje v skladu z ustreznimi zahtevami iz točk 2.5.1.2, 2.5.1.3, 2.5.1.4 in 2.5.2.
No authorisation shall be granted if the concentration of the active substance or of relevant metabolites, degradation or reaction products in groundwater, may be expected to exceed, as a result of use of the plant protection product under the proposed conditions of use, the lower of the following limit values:
Registracija se ne odobri, če se kot rezultat uporabe fitofarmacevtskega sredstva pri predlaganih pogojih uporabe pričakuje, da bo koncentracija aktivne snovi, relevantnih metabolitov, razgradnih ali reakcijskih produktov v podtalnici presegla naslednje mejne vrednosti:
the maximum permissible concentration laid down by Directive 2006/118/EC of the European Parliament and of the Council [9]; or
največjo dopustno koncentracijo iz Direktive 2006/118/ES Evropskega parlamenta in Sveta [9] ali
the maximum concentration laid down when approving the active substance in accordance with Regulation (EC) No 1107/2009, on the basis of appropriate data, in particular toxicological data, or, where that concentration has not been laid down, the concentration corresponding to one tenth of the ADI laid down when the active substance was approved in accordance with Regulation (EC) No 1107/2009,
največjo koncentracijo, določeno na podlagi ustreznih, zlasti toksikoloških podatkov ob odobritvi aktivne snovi v skladu z Uredbo (ES) št. 1107/2009, ali kadar navedena koncentracija ni določena, koncentracijo, ki ustreza desetini vrednosti sprejemljivega dnevnega vnosa, določenega ob odobritvi aktivne snovi v skladu z Uredbo (ES) št. 1107/2009;
unless it is scientifically demonstrated that under relevant field conditions the lower concentration is not exceeded.
razen če se znanstveno dokaže, da v relevantnih terenskih razmerah manjša koncentracija ne bo presežena.
No authorisation shall be granted if the concentration of the active substance or of relevant metabolites, breakdown or reaction products to be expected after use of the plant protection product under the proposed conditions of use in surface water:
Registracija se ne odobri, če koncentracija aktivne snovi ali relevantnih metabolitov, razgradnih ali reakcijskih produktov po uporabi fitofarmacevtskih sredstev pri predlaganih pogojih uporabe v površinski vodi:
exceeds, where the surface water in or from the area of envisaged use is intended for the abstraction of drinking water, concentrations above which compliance with drinking water quality established in accordance with Directive 2000/60/EC of the European Parliament and of the Council [10] is compromised, orhas an impact deemed unacceptable on non-target species, including animals, in accordance with the relevant requirements provided for in point 2.5.2.
preseže, kadar je površinska voda na območju predvidene uporabe ali z njega namenjena za zajemanje pitne vode, mejne koncentracije za pitno vodo iz Direktive 2000/60/ES Evropskega parlamenta in Sveta [10] aliima nesprejemljiv vpliv na neciljne vrste, vključno z živalmi, v skladu z ustreznimi zahtevami iz točke 2.5.2.
The proposed instructions for use of the plant protection product, including procedures for cleaning application equipment, must be such that the likelihood of accidental contamination of surface water is reduced to a minimum.
Predlagana navodila za uporabo fitofarmacevtskega sredstva, vključno s postopki za čiščenje opreme za nanašanje, morajo biti taka, da je verjetnost naključne kontaminacije površinske vode zmanjšana na minimum.
No authorisation shall be granted if the airborne concentration of the active substance under the proposed conditions of use is such that either the AOEL or the limit values for operators, bystanders or workers as referred to in point 2.4.1 are exceeded.
Registracija se ne odobri, če je koncentracija aktivne snovi v zraku pri predlaganih pogojih uporabe taka, da so presežene vrednosti sprejemljive ravni izpostavljenosti izvajalca tretiranja ali mejne vrednosti za izvajalce tretiranja, druge navzoče osebe ali delavce, kot je navedeno v točki 2.4.1.
the acute and short-term toxicity/exposure ratio for birds and other non-target terrestrial vertebrates is less than 10 on the basis of LD50 or the long-term toxicity/exposure ratio is less than 5, unless it is clearly established through an appropriate risk assessment that under field conditions no unacceptable impact occurs after use of the plant protection product in accordance with the proposed conditions of use,
je razmerje med akutno in kratkotrajno toksičnostjo ter izpostavljenostjo za ptice in druge neciljne kopenske vretenčarje manjše od 10 na podlagi LD50 ali je razmerje med dolgotrajno toksičnostjo in izpostavljenostjo manjše od 5, razen če se z ustrezno oceno tveganja jasno dokaže, da fitofarmacevtsko sredstvo v terenskih razmerah uporabe nima nesprejemljivega vpliva pod predlaganimi pogoji uporabe,
the bioconcentration factor (BCF, related to fat tissue) is greater than 1, unless it is clearly established through an appropriate risk assessment that under field conditions no unacceptable effects occur — directly or indirectly — after use of the plant protection product in accordance with the proposed conditions of use.
je biokoncentracijski faktor (BCF, se nanaša na maščobno tkivo) večji od ena, razen če se z ustrezno oceno tveganja jasno dokaže, da uporaba fitofarmacevtskega sredstva v terenskih razmerah uporabe nima nesprejemljivega – posrednega ali neposrednega – vpliva po uporabi pripravka pod predlaganimi pogoji uporabe.
Where there is a possibility of aquatic organisms being exposed, no authorisation shall be granted if:
Kadar obstaja možnost za izpostavljenost vodnih organizmov, se registracija ne odobri, če:
the toxicity/exposure ratio for fish and Daphnia is less than 100 for acute exposure and less than 10 for long-term exposure, or
je razmerje med toksičnostjo in izpostavljenostjo za ribe in dafnije manjše od 100 za akutno izpostavljenost in manjše od 10 za dolgoročno izpostavljenost ali
the algal growth inhibition/exposure ratio is less than 10, or
je razmerje med inhibicijo rasti alg in izpostavljenostjo manjša od 10 ali
the maximum bioconcentration factor (BCF) is greater than 1000 for plant protection products containing active substances which are readily biodegradable or greater than 100 for those which are not readily biodegradable,
je največji biokoncentracijski faktor (BCF) večji od 1000 za fitofarmacevtska sredstva z biološko lahko razgradljivimi aktivnimi snovmi ali večji od 100 za pripravke, ki so biološko težje razgradljivi,